The PARTNER 3 Trial - Facts for the Referring Provider

The PARTNER 3 trial is a national study determining the safety and effectiveness of transcatheter aortic valve replacement (TAVR) using the Edwards SAPIEN 3 (3nd generation) device in the low risk for surgical aortic valve replacement (AVR) population.

Download Document

The browser you're using does not support embedded PDFs. Please click the button above to download a copy of this document.